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SUMMARY · Every suspicion of thromboembolic disease requires urgent therapy decision because
of the potential life-threatening complications. Routine measurement of plasma D-dimer levels has
alleviated this delicate problem. In this study, D-dimers were measured in 49 out of 121 patients
admitted to the Department of Medicine from 1997 till 1999 for suspected thromboembolic disease.
The selection of these 49 patients was based on the high probability of pulmonary embolism on
ventilation/perfusion lung scan or clinical signs of deep venous thrombosis and positive isotope venog-
raphy. Increased D-dimer levels were found in all 49 cases. The patients were classified according to
the extension of the thrombotic incident. Higher D-dimer values were recorded in patients with
massive or submassive pulmonary embolism (mean 5.6 ng/L) as compared to those with segmental
pulmonary embolism (mean 2.6 ng/L). D-dimer levels in patients with ileofemoral thrombosis were
much higher (mean 5.2 ng/L) than in patients with calf thrombosis (mean 1.6 ng/L). One patient
with calf thrombosis had a borderline level of 0.3 ng/L (normal value: up to 0.3 ng/L). Although a
positive correlation between thrombus size and D-dimer levels has been demonstrated, other factors
may also influence test results, e.g., disseminated intravascular coagulation, intensity of fibrinolysis,
and simultaneous thrombosis of unrecognized localization.
Key words: Fibrin · fibrinogen degradation products, analysis; Pulmonary embolism, diagnosis; Venous
thrombosis, diagnosis
Introduction
In spite of the progress in medical technology, pulmo-
nary embolism (PE) and deep venous thrombosis (DVT)
remain a serious diagnostic problem1. In severe forms of
thromboembolic disease (TED), diagnostic procedures
cannot be performed at a rate at which pulmonary em-
bolism may threaten the patient’s life. For the same rea-
son, clinicians are quite frequently forced to make the
diagnosis only on the basis of history data, clinical mani-
festations, and routine laboratory tests. In such an emer-
gency, PE and DVT may clinically resemble several other
diseases, thus making therapeutic decision more difficult2.
The introduction of D-dimer assays into clinical practice
was widely welcome and accepted by physicians because
of its remarkable contribution to accurate diagnosis of
TED.
Our first trials in the determination of D-dimer lev-
els were initiated in the late 1994. We started to use en-
zyme-linked immunosorbent assay (ELISA) in collabo-
ration with Dr. Godec from the Croatian Institute of
Transfusion Medicine from Zagreb. At the time, prelimi-
nary results indicated that the test reliability was consid-
erably influenced by sample transportation and process-
ing speed. The introduction of this method at our own
coagulation laboratory provided an opportunity for fast
and safe sample processing with reliable results. It opened
up the possibility of D-dimer detection and evaluation in
TED, which was precisely the aim of the present study.
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Patients and Methods
In the period between January 1997 and July 1999, 121
patients were admitted to the Department of Medicine for
suspected TED. The diagnosis of PE or DVT was made
in 49 patients (30 women and 19 men, mean age 63.2 and
62.5 years, respectively). Only patients with acute symp-
toms of illness lasting for not more than 72 hours were in-
cluded. Routine laboratory tests were performed on admis-
sion (ECG, acid-base balance, chest x-ray). A high prob-
ability of PE on ventilation/perfusion (V/P) lung scan was
found in 25 patients. Typical clinical signs and isotope
venography performed by sodium pertechnetate Te 99m
were sufficient for the diagnosis of DVT in 24 patients.
Both PE and DVT were found in 12 patients. The patients
were classified according to predominant clinical manifes-
tations and laboratory data into PE and DVT group. In the
PE group, 11 patients had massive or submassive PE, and
14 had segmental PE. In the DVT group, calf thrombosis
and ileofemoral thrombosis was detected in 14 and ten
patients, respectively.
D-dimers were measured on admission in citrated
platelet-free plasma by rapid immunoassay (Nyco-Card D-
Dimer, Axis-Shield PoC AS, Oslo, Norway) and results
were read off by the NycoCard Reader (measuring range
0.1-20.0 mg/L; measuring intervals 0.1 mg/L). Mono-
clonal antibodies specific for neoantigen on D-dimer struc-
ture are used in the test. Normal values stated by the manu-
facturer and at our laboratory were up to 0.3 ng/L.
Patients with extremely rapid or extremely slow fibrin-
olysis on admission were excluded from the study.
Results
D-dimer levels in patients with different TEDs are
shown in Fig. 1. Patients with massive, submassive or seg-
mental PE, and those with calf or ileofemoral thrombo-
sis are specially marked.
Increased plasma D-dimer levels were found in all 49
patients with PE or DVT. Only one patient with calf
thrombosis had a borderline D-dimer value (0.3 ng/L).
DVT=deep venous thrombosis; ileofemoral ;
calf thrombosis ;
pulmonary embolism massive or submassive ;
segmental 
Fig. 1. Scatterplot of D-dimer levels in patients with different thromboembolic diseases.
D-dimers DVT PE
m. v.    = 5.2
m. v.    = 1.6
m. v.    = 5.6
m. v.    = 2.6
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Most of the patients with massive or submassive PE had
D-dimer levels ranging from 2 to 8 ng/L, mean 5.6 ng/
L, and those with segmental PE from 1.5 to 4 ng/L, mean
2.6 ng/L. Patients with ileofemoral thrombosis also had
elevated D-dimer levels, ranging from 2 to 8 ng/L, mean
5.2 ng/L as compared to those with calf thrombosis, in
whom they ranged from 0.5 to 6 ng/L, mean 1.6 ng/L.
Discussion
The study showed pathologic, increased D-dimer lev-
els in all patients with acute TED except for one border-
line case (0.3 ng/L). The results of the study are consis-
tent with those reported elsewhere3-7. However, although
highly sensitive, the methods used in PE and DVT di-
agnosis are much less specific. Therefore, only patients
with a high probability of PE on V/P lung scan were se-
lected for the study. Clinically suspect DVT was verified
by isotope venography.
Considerably higher values were recorded in patients
with massive or submassive PE as well as in those with
ileofemoral thrombosis. These observations require fur-
ther evaluation, although a proportional correlation be-
tween thrombus size and degradation product levels may
be expected. This correlation was demonstrated by
Hansson et al.8 in 28 patients with proximal and distal
DVT. A definite advantage of measuring D-dimer levels
was shown by Goldhaber et al.9. They report on 45 pa-
tients with pulmonary embolism verified by angiography.
Increased D-dimer levels were present in 42 cases. Non-
significant D-dimer values were found in the remaining
three patients. Two of them had residual pathologic
changes of previous DVT but there was no proper expla-
nation in the third patient. Ginsberg et al.10 report on 197
patients with verified PE. The sensitivity of D-dimer lev-
els was 84.4%, however, the specificity was much lower,
i.e. 68.4%. The authors point out that normal venous pl-
ethysmography and D-dimer level do not require any
additional diagnostic procedure. Perrier et al.11 have sug-
gested a diagnostic algorithm in the following order: clini-
cal manifestations and D-dimer level together with
venous ultrasonography and/or V/P lung scan.
A very simplified approach has been proposed by
Egermayer et al.4. Normal D-dimer findings, pO2 >80
mm Hg, and respiratory rate <20/min exclude PE with a
high significance. Bradley et al.12 showed a high D-dimer
sensitivity (97.7%) in patients with DVT verified by ul-
trasonography. Just one false-positive test was found.
On the other hand, specificity was only 48.9%, with 45
false-positive findings. According to Ryn et al.13 and other
sources, the sensitivity of elevated D-dimer levels in the
diagnosis of PE ranges from 73% to 100%. The specificity
varies widely, depending on the assay used and the patient
studied. A specificity of 30% to 70% was recorded in larger
studies. A recent prospective study using 5 different latex
agglutination assays showed a normal D-dimer level to have
a high negative predictive value of 94% - 100% in exclud-
ing PE14. Most authors6-9 consider D-dimer test very use-
ful when clinical suspicion of thromboembolism is low or
moderate. Conversely, when high clinical suspicion of TED
is present, a negative D-dimer test should be ignored. An
interesting question was raised by Romero-Garcia et al.15.
Their study indicates the prognostic benefit of measuring
D-dimer levels in obstetric patients with thrombosis risk
factors. As shown by these results, a moderate increase in
D-dimer levels (up to twofold upper normal limit) was re-
corded in 78% of pregnant women with a history of TED.
The same increase was observed in 60% of cesarean deliv-
eries, 37% of hypertensive and 23% of diabetic pregnancies.
Pregnant women with a fourfold D-dimer level increase
developed clinical manifestations of TED. However, these
results were not confirmed by some other authors16. Ac-
cording to Fischbach17, an expert in laboratory diagnosis,
these data should be taken with some reserve. Higher D-
dimer levels are normally present in late pregnancy and
postpartal period. Therefore, their prognostic value in such
a period is questionable. Additional diagnostic procedures
in pregnant women with high D-dimer levels and a high
risk of thrombotic factors appear to be reasonable. In his
manual of laboratory tests17, Fischbach points out very
clearly that D-dimers are more specific for disseminated in-
travascular coagulation (secondary fibrinolysis) but are use-
ful in TED as well. The level of D-dimers will also be higher
in malignancies, inflammatory diseases (sepsis), primary
fibrinolysis, cardiac insufficiency, and in elderly patients.
Fischbach also points out that D-dimers can be false-posi-
tive if a high rheumatoid factor titer or high CA-125 tu-
mor marker value (ovarian cancer) is present.
As shown by Shorr et al.18, critically ill patients often
have elevated concentrations of D-dimers in the absence
of TED.
Conclusion
We found increased D-dimer levels in all patients in-
cluded in the study, had they PE or DVT. Generally, more
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extensive local thrombosis or thromboembolism was as-
sociated with higher D-dimer levels. However, the pos-
sibility of asymptomatic thrombotic incidents of other
localizations should be considered at the same time as
well. Segmental PE or calf thrombosis induced lower or
borderline values, which makes this useful test less reli-
able.
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Saæetak
D-DIMERI U DIJAGNOSTICI TROMBOEMBOLIJSKIH BOLESTI
Æ. VuËiÊeviÊ i T. ©u¹koviÊ
Svaka sumnja na tromboembolijsku bolest zahtijeva hitno odluËivanje o terapiji zbog moguÊih komplikacija opasnih za
æivot. Rutinsko mjerenje razina D-dimera u plazmi ublaæilo je ovaj delikatan problem. U ovom su ispitivanju D-dimeri mjereni
u 49 od 121 bolesnika primljenih na Kliniku za unutarnje bolesti izmeðu 1997. i 1999. godine zbog sumnje na tromboembolijsku
bolest. Ovih je 49 bolesnika odabrano na osnovi visoke vjerojatnosti pluÊne embolije utvrðene prigodom ventilacijsko/perfuzijskog
snimanja pluÊa ili prema kliniËkim znacima duboke venske tromboze i pozitivne izotopne venografije. Povi¹ene razine D-
dimera naðene su u svih 49 bolesnika. Bolesnici su razvrstani prema razmjeru trombotskog ispada. Vi¹e vrijednosti D-dimera
zabiljeæene su u bolesnika s masivnom ili submasivnom pluÊnom embolijom (srednja vrijednost 5,6 ng/L) u usporedbi s onima
sa segmentnom pluÊnom embolijom (srednja vrijednost 2,6 ng/L). Razine D-dimera u bolesnika s ileofemoralnom trombozom
bile su znatno vi¹e (srednja vrijednost 5,2 ng/L) nego u bolesnika s trombozom potkoljenice (srednja vrijednost 1,6 ng/L).
Jedan je bolesnik s trombozom potkoljenice imao graniËnu vrijednost od 0,3 ng/L (normalna vrijednost: do 0,3 ng/L). Iako
je dokazana pozitivna korelacija izmeðu veliËine tromba i razina D-dimera, postoje i drugi Ëimbenici koji mogu utjecati na
razultate pretrage, a to su diseminirana intravaskularna koagulacija, intenzitet fibrinolize i istodobna tromboza nepoznate
lokalizacije.
KljuËne rijeËi: Proizvodi razgradnje fibrina · fibrinogena, analiza; PluÊna embolija, dijagnostika; Venska tromboza, dijagnostika
